Boston Trust Walden’s Silgan Holdings SLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9M Sell
839,511
-74,373
-8% -$2.97M 0.3% 120
2026
Q1
$35.5M Sell
913,884
-619,895
-40% -$27.2M 0.29% 125
2025
Q4
$61.9M Sell
1,533,779
-95,251
-6% -$3.87M 0.47% 78
2025
Q3
$70.1M Sell
1,629,030
-17,903
-1% -$866K 0.51% 70
2025
Q2
$89.2M Sell
1,646,933
-209,368
-11% -$11.1M 0.64% 47
2025
Q1
$94.9M Sell
1,856,301
-20,856
-1% -$1.09M 0.69% 41
2024
Q4
$97.7M Sell
1,877,157
-4,793
-0.3% -$256K 0.69% 39
2024
Q3
$98.8M Sell
1,881,950
-2,659
-0.1% -$129K 0.69% 37
2024
Q2
$79.8M Buy
1,884,609
+322,511
+21% +$15M 0.59% 52
2024
Q1
$75.9M Sell
1,562,098
-4,350
-0.3% -$193K 0.54% 61
2023
Q4
$70.9M Buy
1,566,448
+10,532
+0.7% +$444K 0.53% 60
2023
Q3
$67.1M Buy
1,555,916
+69,852
+5% +$3.13M 0.56% 55
2023
Q2
$69.7M Buy
1,486,064
+60,180
+4% +$2.93M 0.57% 59
2023
Q1
$76.5M Buy
1,425,884
+466,104
+49% +$24.6M 0.66% 44
2022
Q4
$49.8M Sell
959,780
-4,842
-0.5% -$237K 0.44% 76
2022
Q3
$40.6M Buy
964,622
+30,653
+3% +$1.35M 0.4% 87
2022
Q2
$38.6M Buy
933,969
+7,406
+0.8% +$326K 0.36% 98
2022
Q1
$42.8M Buy
926,563
+20,606
+2% +$893K 0.35% 103
2021
Q4
$38.8M Sell
905,957
-7,019
-0.8% -$290K 0.31% 113
2021
Q3
$35M Buy
912,976
+18,260
+2% +$744K 0.31% 116
2021
Q2
$37.1M Buy
894,716
+120,394
+16% +$5.11M 0.33% 111
2021
Q1
$32.5M Sell
774,322
-7,894
-1% -$308K 0.32% 115
2020
Q4
$29M Buy
782,216
+602
+0.1% +$21.7K 0.31% 113
2020
Q3
$28.7M Buy
781,614
+35,434
+5% +$1.3M 0.36% 84
2020
Q2
$24.2M Sell
746,180
-16,595
-2% -$540K 0.33% 97
2020
Q1
$22.1M Sell
762,775
-282,820
-27% -$8.51M 0.35% 85
2019
Q4
$32.5M Buy
1,045,595
+20,376
+2% +$623K 0.38% 80
2019
Q3
$30.8M Buy
1,025,219
+125,473
+14% +$3.78M 0.39% 80
2019
Q2
$27.5M Buy
899,746
+118,934
+15% +$3.55M 0.36% 83
2019
Q1
$23.1M Buy
780,812
+27,929
+4% +$770K 0.32% 94
2018
Q4
$17.8M Sell
752,883
-45,150
-6% -$1.14M 0.28% 103
2018
Q3
$22.2M Sell
798,033
-18,617
-2% -$511K 0.31% 100
2018
Q2
$21.9M Buy
816,650
+103,917
+15% +$2.86M 0.32% 98
2018
Q1
$19.8M Sell
712,733
-29,152
-4% -$835K 0.3% 102
2017
Q4
$21.8M Buy
741,885
+36,463
+5% +$1.06M 0.32% 100
2017
Q3
$20.8M Sell
705,422
-4,146
-0.6% -$126K 0.32% 96
2017
Q2
$22.6M Sell
709,568
-145,578
-17% -$4.49M 0.36% 85
2017
Q1
$25.4M Sell
855,146
-483,408
-36% -$14.2M 0.4% 92
2016
Q4
$34.3M Buy
1,338,554
+144,570
+12% +$3.64M 0.54% 60
2016
Q3
$30.2M Sell
1,193,984
-5,188
-0.4% -$129K 0.5% 70
2016
Q2
$30.9M Buy
1,199,172
+293,686
+32% +$7.55M 0.53% 64
2016
Q1
$24.1M Buy
905,486
+178,350
+25% +$4.63M 0.42% 85
2015
Q4
$19.5M Sell
727,136
-273,276
-27% -$7.22M 0.36% 106
2015
Q3
$26M Sell
1,000,412
-42,094
-4% -$1.11M 0.43% 86
2015
Q2
$27.5M Sell
1,042,506
-3,122
-0.3% -$86.5K 0.42% 102
2015
Q1
$30.4M Buy
1,045,628
+982,628
+1,560% +$27.3M 0.45% 93
2014
Q4
$1.69M Buy
63,000
+600
+1% +$15.1K 0.03% 257
2014
Q3
$1.47M Sell
62,400
-1,000
-2% -$25K 0.02% 257
2014
Q2
$1.61M Buy
+63,400
New +$1.57M 0.02% 247

Other funds holding SLGN

Boston Trust Walden's SLGN Position: Q2 2026 in Review

Boston Trust Walden reduced its Silgan Holdings (SLGN) stake by 8.1% in Q2 2026, selling an estimated $2.97M and leaving 839,511 shares worth $38.9M. The position accounts for 0.3% of the portfolio, ranked #120.

Boston Trust Walden first reported a position in SLGN in Q2 2014 and has held it in 49 quarters since. The position peaked at $98.8M in Q3 2024. 83 funds tracked by Wall St. Rank hold SLGN as of Q2 2026.

  • Boston Trust Walden held 839,511 shares of Silgan Holdings worth $38.9M as of Q2 2026.
  • Boston Trust Walden sold 74,373 Silgan Holdings shares in Q2 2026, an estimated $2.97M.
  • Silgan Holdings made up 0.3% of Boston Trust Walden's portfolio in Q2 2026, its #120 holding.
  • Boston Trust Walden first reported a position in Silgan Holdings in Q2 2014 and has held it in 49 quarters since.
  • Boston Trust Walden's Silgan Holdings position peaked at $98.8M in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Silgan Holdings as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.